PASI Reductions for an Oral TYK2 InhibitorJeremy VisserJul 14, 20231 min readDr. Ronald B. Vender reviews a poster about the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
Dr. Ronald B. Vender reviews a poster about the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
Comments